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Abstract
Introduction: The aim of the study was to translate, adapt and validate the Celiac Disease Questionnaire (CDQ),
which was developed in Germany, for use in Turkey.
Methods: The questionnaire was translated by a forward-backward translation method. Total CDQ score and four
subscores (emotional state, gastrointestinal symptoms, worries, social problems) were calculated and their reliability
assessed by internal consistency. Reliability of scales was evaluated by internal consistency. Test-retest reliability was
assessed by means of a retest after 15 days. Face validity was assessed by patient volunteers and physicians and
construct validity was assessed by means of confirmatory factor analysis. Convergent validity was determined by
comparing responses to the CDQ with similar subscale scores of the Short Form-36 (SF-36) health survey. Discriminative
concurrent criterion validity was determined by comparing the CDQ scores of patients with celiac disease (CD) on a
gluten-free diet (GFD) with CD patients not on a GFD.
Results: The Turkish version of the CDQ was completed by 205 patients with celiac disease (Female 146, mean
age 31.1 year, ± 10.61). The Cronbach-α coefficent of the subscores ranged between 0.73 and 0.93. Test-retest
reliability was 0.99 for all subscores. 42 patients with CD and five gastroenterologists assessed the items of the
CDQ to be comprehensible and relevant to the health related quality of life (HRQOL) of CD patients. The confirmatory
factor analysis demonstrated acceptable fit indices for the original four subscales of the CDQ. The correlations between
the scales of the CDQ and the instrument for validation covering similar dimensions of the HRQOL ranged between
0.61 and 0.93. In all subscores and in the total score, patients not on a GFD showed a significantly reduced HRQOL (all
p < 0.05) compared to patients on a GFD.
Conclusion: The Turkish version of the CDQ proved to be a reliable and valid instrument for measuring HRQOL in
Turkish patients with celiac disease.
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Introduction
Celiac disease (CD), is a prevalent chronic auto-
immune disorder that is triggered by the ingestion of
wheat gluten and related proteins of rye and barley in
genetically susceptible individuals [1–4]. According to
the results of different recently-published studies, CD
affects between 1:100 and 1:200 individuals in the
general population of Turkey [5–7]. Currently the
cornerstone of the treatment is a lifelong strict gluten-
free diet (GFD) [8], under which gluten is entirely
eliminated from food intake and medications. Adherence
to a GFD has a positive effect in general on the medical
condition of CD patients [1] and, following introduction
of the GFD, most patients with CD show improvement
not only in terms of gastrointestinal symptoms but also
with regards to their psychological well-being. Study
results imply that before starting the diet, even CD
patients classified as asymptomatic may in fact have had
mild symptoms of which they became aware only after
having being prescribed a gluten-free diet [9]. Compliance
with the diet has been found to be a factor associated with
health related quality of life (HRQOL) [10–12], and with
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improved quality of life in the majority of patients with
CD [4, 13, 14].
In recent years, there has been increased medical
interest in patients’ subjective perception of the impact
chronic disorders have on their lifestyle and general state
of health. These factors have therefore become import-
ant criteria when assessing the effectiveness of thera-
peutic intervention [15, 16]. Two basic approaches have
been developed for the measurement of quality of life:
generic instruments that provide a summary of HRQOL;
and specific instruments that focus on problems associ-
ated with particular disease states, patient groups, or
areas of function [16]. Generic instruments do not assess
specific aspects of a certain disease such as the possible
social and financial restrictions associated with adher-
ence to a GFD in CD, and are considered to be less
sensitive to changes in the patients’ health state [17].
Therefore, the use of disease-specific HRQOL instru-
ments is necessary for clinical studies in gastroenter-
ology [17, 18]. The Celiac Disease Questionnaire (CDQ)
is a disease–specific HRQOL questionnaire developed
and validated for adult CD patients [17]. Good psycho-
metric properties have been demonstrated for both the
German [17] and the Italian version [19].
The purpose of the present study was to translate and
validate the CDQ [17] for use in Turkey.
Methods
Translation
Two bilingual medical doctors and two interpreters
worked on the translation of the CDQ into Turkish. The
English version was used as the basis for translation.
Translation was carried out by the forward-backward
method: First, one bilingual doctor translated the ques-
tionnaire from English into Turkish. Subsequently, it
was translated back into English by the other bilingual
doctor. Finally, these two doctors met together with two
interpreters and a doctor with expertise in the field of
celiac disease to compare the two English versions and
the Turkish translation, and to reconcile discrepancies in
order to create one single version.
The abbreviation “CDQ” was kept for the Turkish
version for ease of international communication. The
Turkish translation of the CDQ is available from the
corresponding author on request.
Patients
Patient members of the Ankara Celiac Association were
recruited into the study. Inclusion criteria were: age >19
and <65 years, CD diagnosis based on duodenal biopsy
showing a certain degree of villous atrophy and positive
endomysial antibodies; the ability to read and under-
stand Turkish; no additional health problems; no vita-
min or trace element supplementation within the last
year; no tobacco or regular alcohol consumption. The
members of Ankara Celiac Association were informed
about the study and its inclusion criteria, and of those
who had volunteered for study participation, 250
randomly-chosen patients were contacted by telephone
or e-mail with a request to complete the CDQ. A total
of 239 CDQs were returned. Two weeks after first
completing the CDQ, a hundred of the same patients
were asked to complete it for a second time. In this
second round, 81 CDQs were returned. In addition, 25
randomly-selected bilingual patients were requested to
fill out the English version of the CDQ to assess whether
the meaning was clear, and whether it was also the same
in both languages (21 of the 25 CDQs were returned).
The 81 patients who had completed the CDQ a second
time were contacted after a further two weeks and asked
to fill out the Short Form-36 (SF-36), a similar HRQOL
questionnaire. All of those contacted returned the SF-36.
Clinical and sociodemographic data of all study partici-
pants were collected in order to prevent misinterpret-
ation of results. All patients included in the study had
given their prior voluntary informed consent after full
written explanation of the aims of the study, including
considerations regarding ethics and data protection.
Psychometric evaluation
Psychometric criteria determined by the IQOLA
(International Quality of Life Assessment) project [20]
were used to assess the psychometric properties of the
Turkish version of the CDQ. Evaluation of data quality
involved the floor and ceiling effect (i.e. the percent-
age of patients scoring the highest or lowest possible
score, where the lowest possible percentage is consid-
ered an acceptable criterion) and completeness of data
(i.e. percentage of items and scales completed, where
90–95 % is considered an acceptable criterion). Scaling
assumptions involved item internal consistency (i.e.
percentage of items with a Pearson item-scale correl-
ation ≥40 %, criterion being 100 %), discriminant
validity (i.e. percentage of items which have a higher
Pearson correlation with other scales than with their
own scale, criterion is 0 %), internal consistency reli-
ability (Cronbach’s alpha coefficient, criterion is >0.7)
and test-retest reliability (Pearson correlation, criterion
is >0.7).
Questionnaires
The CDQ is an instrument consisting of 28 items di-
vided into four subscales : emotion (seven items), gastro-
intestinal symptoms (seven items), worries (seven items),
social problems (seven items). The emotional states
include depressed, relaxed, happy, restless, physically fa-
tigued and tearful; gastrointestinal symptoms include ab-
dominal cramps, bloating, incomplete bowel evacuation,
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loose bowels, aberrant bowel movement, belching and
nausea; worries include fear of medical examinations,
health insurance issues, fear of cancer, fears concerning
inheritance to children, gluten-free diet costs and con-
cerns associated with living a gluten-free life; social
problems include lack of social understanding, exclu-
sion from others, family/friends, sports, a professional
career, social or meal invitations and sexual activities
[17, 19].
Each subscale is scored using a seven point Likert
scale in which “7” corresponds to the best state and “1”
to the worst, with 2 of the items requiring reverse
coding. The scores of each area range from 0 to 49 and
the total CDQ score ranges from 0 to 196 [17].
The sociodemographic questionnaire includes demo-
graphic questions to assess gender, marital status, age,
lifestyle variables (regular cigarette smoking, regular
alcohol intake, regular participation in sport), present
occupational status and educational status.
The medical questionnaire includes questions to assess
medical history of the disease, adherence to a gluten-free
diet, body mass index, prior or current celiac-associated
disease, other diseases and current medication.
The Medical Outcome Study Short Form-36 (SF-36)
[21] was used for validation. SF-36 has been shown to
be a reliable and valid instrument in Turkish patients
[22], and consists of 36 items with eight subscales: phys-
ical functioning (ten items), social functioning (two
items), role limitations due to physical problems (four
items), role limitations due to emotional problems (three
items), mental health (five items), energy and vitality
(four items), pain (two items), and general perception of
health (five items). For each variable item, scores are
coded, added and transformed onto a scale from 0
(worst possible health state measured by the question-
naire) to 100 (best possible health state) [21, 22].
Validation methods and hypothesis
The methods used to validate the CDQ were as follows:
 Acceptance, assessed by the proportion of missing
or invalid items.
 Reliability of the scales, assessed by internal
consistency as determined by Cronbach’s α
coefficient, which measures the overall correlation
between items within a scale. A correlation level of
0,7 and higher is considered desirable [23].
 Test-retest reliability was assessed in 81 patients
who completed the CDQ twice within 15 days.
 Face validity in CD patients had been assessed in
German subjects for the original questionnaire [17].
In this research, face validity of the Turkish version
was evaluated by 42 patients with CD and five
physicians. We tested face validity by asking the
patients and physicians to evaluate whether the
CDQ subsections were relevant or irrelevant to CD.
 Factorial/construct validity was assessed by
confirmatory factor analysis, which was used to
confirm the factors or sub-scales determined in the
original scale. Normed fit index (NFI), comparative
fit index (CFI) and chi-squared statistics were used
for evaluating model fit.
 Convergent validity was determined by comparing
responses to the CDQ with similar subscale scores
of the SF-36, which has been shown to be a reliable
and valid instrument in Turkish patients. The
convergent validity was fulfilled when the scale

















Primary school graduate 8 3.9
Middle school graduate 17 8.3
High school graduate 71 34.6
College graduate 103 50.2
Compliance to gluten-free diet
All of the time 143 69.8
A good bit of the time 44 21.5
Some of the time 15 7.3
Hardly any of the time 2 1.0
None of the time 1 0.5
Income status
<1000 TLa 46 22.4
1000–2000 TLa 69 33.7
2000–3000 TLa 39 19.0
3000–4000 TLa 26 12.7
4000–5000 TLa 7 3.4
>5000 TLa 18 8.8
aTL means Turkish Liras
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scores for related concepts showed moderate to
high correlation (Spearman rank correlation
coefficients >0,4) [23]. The expectation is of a
higher correlation in similar dimensions (shown
bold in Table 3) and a lower correlation in
dissimilar dimensions, indications that the CDQ
has clear outcomes.
 Discriminant concurrent criterion validity was
determined by comparing the CDQ scores of
patients with CD on a GFD with those patients not
on a GFD. We predicted that patients on a GFD
would show increased HRQOL scores compared
with patients not on a GFD.
Statistical analysis
The Statistical Package for Social Sciences (SPSS 21.0
package for Windows) was used to analyze the data.
Descriptive statistics were applied to report continuous
variables as means ± standard deviation (SD). Categorical
data were given as counts and percentages. Chi-square
and Analysis of Variance (ANOVA) were used for ana-
lysis of categorical and continuous data, respectively,
while the correlation between CDQ and other dependent
variables were described by Pearson and Spearman
correlation tests. Pearson correlation analysis was
calculated for normally-distrubuted and Spearman cor-
relation for abnormally-distributed variables.
Confirmatory factor analysis was executed to deter-
mine factorial/construct validity. NFI (>0.90 accept-
able fit), CFI (>0.90 acceptable fit), Root Mean Square
Residual (<0.08 acceptable fit) were calculated and
chi-squared statistics were used for evaluating model
fit [24].
Cronbach’s alpha was computed in order to assess in-
ternal consistency and test–retest reliability, respectively.
Discriminant validity was evaluated by Mann Whitney
rank-sum test. All tests were two-tailed with the signifi-
cance level set at p < 0.05.
The study was approved by Hacettepe Üniversitesi
Girişimsel Olmayan Klinik Araştırmalar Etik Kurulu
with the reference number HEK 12/113–24.
Results
Patients
Twenty-one patients were excluded due to the exclusion
criteria of the study (12 patients due to tobacco con-
sumption, 9 patients due to additional health problems),
while thirteen patients originally included in the study
could not be contacted or were considered to be lost to
follow-up and eleven patients never returned the ques-
tionnaire. At study completion, two hundred and five
(146 females, 59 males, mean age 31.1 years ± 10.61) pa-
tients with CD were included. Sociodemographic and
medical data of the patients are presented in Table 1.
Psychometric evaluation
Floor and ceiling effect was found to be 0 % for the total
score, 1 % for the emotional and social subscale scores,
and 0 % for the worries and gastrointestinal symptoms
subscale scores. Completeness of data was 100 %, item
internal consistency was 100 %, discriminant validity was
0 %, minimum internal consistency reliability was 0.73,
and minimum test-retest reliability was 0.99. Based on
Table 2 The Internal consistency and test-retest reliability of
CDQ subscales (n = 81)







Emotion 28.6(9.0) 0.93 0.99
Social 34.0(8.1) 0.75 0.99
Worries 28.0(8.5) 0.73 0.99
Bowel 34.2(8.3) 0.86 0.99
Total 124.8(28.1) 0.99
Table 3 Correlations of the CDQ with SF 36 subscales (Spearman Correlation)
CDQ Items
Emotion Social Worries Gastrointestinal Total
SF-36 Items
Physical function 0.52 (<0.001) 0.49(<0.001) 0.40(0.001) 0.68(<0.001) 0.67(<0.001)
Role-physical 0.50(<0.001) 0.45(<0.001) 0.38(0.002) 0.61(<0.001) 0.62(<0.001)
Bodily pain 0.52(<0.001) 0.37(0.003) 0.24(0.055) 0.85(<0.001) 0.57(<0.001)
General health perception 0.54(<0.001) 0.55(<0.001) 0.56(<0.001) 0.69(<0.001) 0.73(<0.001)
Vitality 0.86(<0.001) 0.52(<0.001) 0.31(0.014) 0.61(<0.001) 0.72(<0.001)
Social functioning 0.59(<0.001) 0.88(<0.001) 0.47(<0.001) 0.46(<0.001) 0.76(<0.001)
Role-emotion 0.63(<0.001) 0.25(0.047) 0.17(0.177) 0.33(0.008) 0.42(0.001)
Mental health 0.93(<0.001) 0.57(<0.001) 0.32(0.009) 0.60(<0.001) 0.75(<0.001)
r = 0.4 to 0.8 expected
The highest rates of correlation for the respective items are shown in bold
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these evaluations, the psychometric properties of the
Turkish version of the CDQ were found to be acceptable.
Reliability
Data on the internal consistency of the scales are pre-
sented in Table 2. Cronbach’s α ranged between 0.73 and
0.93, and test-retest reliability was 0.99 for all subscales.
Validity
Face validity; 42 volunteers recruited from the partici-
pating patients with CD and all physicians assessed the
items of the CDQ to be comprehensible, and indicated
that the items were relevant to HRQOL for CD pa-
tients. The patients and the doctors agreed that the
listed CDQ items are relevant issues for individuals
with celiac disease.
Construct validity; The subscale characteristics are
presented in Table 3. There were no significant differ-
ences in the CDQ subscales or in the total score
between males and females or between patients of
different educational backgrounds. Furthermore, there
were no significant correlations with age (Table 4).
Confirmatory factor analysis was performed to verify
the construct validity of the scale. As a result of analysis
of the model, fit indices were examined (NFI = 0.91,
CFI = 0.93, RMR = 0.073). Accordingly, the chi-square
value was found to be statistically significant (χ2 =
794.79, p <0.001, χ2/dfa: 794.79/344 = 2,31). Fit indices
accepted < 5 for χ2/dfa, >0.90 for NFI and CFI, <0.08
for RMR [23].
Convergent validity; The correlations (Spearman rank-
order correlation) between the scales of the CDQ and the
instrument for validation covering similar dimensions of
the HRQOL ranged between 0.61 and 0.93 (Table 3). High
scores in CDQ and SF-36 indicate a good HRQOL.
Discriminant concurrent criterion validity: Differences
in the CDQ subscales between patients on a GFD and
those not on a GFD are presented in Table 5. In all sub-
scales and in terms of total score, patients not on a GFD
showed a significantly reduced HRQOL (total p < 0.05)
compared to patients adhering to a GFD.
Discussion
The number of individuals diagnosed with celiac disease
has increased in recent years [25]. Due to the necessity
for lifelong changes in lifestyle in persons with CD,
health-related quality of life has become an important
focus of attention [17, 26].
The CDQ is an economic, reliable and valid disease-
specific instrument for the assessment of HRQOL in pa-
tients with CD [17]. In this study, the Turkish adaptation
of the CDQ was validated for the first time for patients
with CD in living Turkey.
Table 4 Subscores of the Turkish CDQ subcategorized by gender, age and education
Emotion Social Worries Gastro-intestinal Total
Mean (SD) p Mean (SD) p Mean (SD) p Mean (SD) p Mean (SD) p
Gender










Female (n = 146) 28.55 (8.95) 34.56 (8.03) 28.32 (8.13) 33.89 (8.37) 125.32 (27.37)
Age










41–64 (n = 44) 30.55 (8.51) 35.91 (7.81) 29.39 (7.06) 34.70 (7.47) 130.55 (25.51)
Educational Level










Literate (n = 5) 32.80 (11.09) 36.00 (8.75) 34.20 (9.96) 40.60 (3.91) 143.60 (21.55)
Primary school
graduate (n = 8)
27.38 (9.07) 33.13 (11.83) 22.75 (9.42) 33.75 (7.42) 117.00 (34.33)
Middle school graduate (n = 17) 32.65 (11.48) 33.59 (7.12) 25.59 (10.82) 37.12 (9.47) 128.94 (35.18)
High school graduate (n = 71) 27.86 (8.96) 33.21 (8.00) 28.38 (8.08) 33.85 (8.68) 123.30 (27.95)
College graduate (n = 103) 28.10 (8.37) 34.45 (8.00) 28.17 (8.05) 33.56 (7.79) 124.27 (26.34)
Table 5 Health-related quality of life of CD patients on a GFD
compared with those not on a GFD, as measured by the Turkish
CDQ
CDQ subscale GFD (n = 143) Not on GFD (n = 62) P
Mean (SD) Mean (SD)
Emotion 29,71 (9.05) 25,90 (8.48) 0.003
Social 35,54 (7.49) 30,40 (8.30) <0.001
Worries 28,84 (8.43) 26,10 (8.38) 0.021
Gastrointestinal 35,46 (7.81) 31,29 (8.60) 0.002
Total 129,55 (26.82) 113,69 (27.90) <0.001
GFD Gluten-free diet
T3
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The enrollment rate of approximately 82 % of patients
who had expressed interest in study participation is
acceptable. A natural sounding, easily comprehensible
translation of the CDQ was obtained in order to reduce
all possible cultural bias to a minimum. Most sociode-
mographic parameters of this Turkish sample are similar
to those of other celiac health surveys in Germany [17]
and Italy [19] but HRQOL scores in all subscales and in
total were lower in this Turkish study population than in
German [17] and Italian [19] samples. Results of the
study show that scale scores were unaffected by the
gender, age and educational backgrounds of those com-
pleting the questionnaire.
Regarding the construct validity of the CDQ, our study
confirmed the factorial structure by confirmatory factor
analysis for the first time. The confirmatory factor ana-
lysis demonstrated the homogeneity of the items and
also the internal consistency to be satisfactory for the
original four dimensions of the CDQ. Furthermore, the
Turkish version of CDQ showed good overall psycho-
metric properties with excellent internal consistency for
the overall score and each of the four subscores.
The correlations of the Turkish CDQ with the SF-36,
an HRQOL scale instrument validated in Turkish, were
significant (Spearman correlation 0.61-0.93) and similar
to the external validity coefficients of other validation
studies of the CDQ [17, 19].
Our analysis also confirmed the ability of the CDQ to
discriminate between patients on a gluten-free diet and
those not on a gluten-free diet. Due to the discriminant
validity of the Turkish questionnaire, the scores of pa-
tients on a gluten-free diet were - as expected - observed
to be significantly higher than in patients who did not
adhere to a gluten-free diet. This criterion was therefore
identified as a classifying parameter.
Some limitations of the study must be considered:
Within the setting of this study, a test of responsiveness
(the ability of a questionnaire to detect clinically important
changes over time) was not possible. The patients were
recruited from the Celiac Disease Association (Çölyak
Derneği) and the selection process offers no guarantee that
these patients were representative for individuals with
celiac disease in the Turkish population as a whole.
Therfore, a potential selection bias in our sample can-
not be entirely excluded.
The use of internationally validated instruments is
strongly recommended to allow international compari-
son of the results of national studies. Transcultural com-
parisons of adult celiac patients can be conducted using
the CDQ. There are also validated celiac-specific quality
of life instruments available for children and adolescents
[27] which should be validated in future.
In conclusion, this study showed the new Turkish ver-
sion of the CDQ to be a valid and reliable instrument
for measuring HRQOL in Turkish patients with celiac
disease. The Turkish version of the CDQ including
information on copyright and contact information are
included in the electronic Additional file 1.
Additional file
Additional file 1: Turkish Version of Celiac Disease Questionnaire (CDQ).
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